El Butlletí de la Recerca es fa ressò de les publicacions indexades a la Web of Science i a Scopus, però també podeu fer-nos arribar les vostres publicacions a través de l’URecerca – Gestió de la Producció Científica que trobareu al Campus Virtual.
The SERPENTINE trial: A phase II clinical study decoding immune responses by scRNA-seq and TCR-seq analysis in patients with MSS metastatic colorectal cancer (Mcrc) with and without liver metastases treated with durvalumab and tremelimumab
Baraibar, I., Morabito, S., Nieto, J., Deuner, G., Melero, J. L., Salva, F., Grzelak, M., Ros Montañá, J., Caratu, G., … Read More
Predictive epigenetic biomarkers of successful weight-loss intervention in pre-pubertal children with obesity
Palmieri, F., Castellano-Escuder, P., Parra-Vargas, M., Leal-Witt, M. J., Krauel, M. R., Lerin, C., Perera, A., & Jiménez-Chillarón, J. C. … Read More
Integrated spatial transcriptomics, single-nucleus RNA sequencing, and histopathology to reveal immune-suppressive niches in colorectal cancer liver metastases
Saoudi Gonzalez, N., Maspero, D., Parreira, I., Ruano, I., Lambert, A., Zeron-Medina, J., Morabito, S., Ruiz, M., Rao, M., Amir-Zilberstein, … Read More
Bevacizumab plus encorafenib-cetuximab in BRAF V600E mutated metastatic colorectal cancer (Mcrc): A phase II study with a safety lead-in cohort (The brave trial)
Ros Montañá, J., Roselló, S., Paez, D., Safont, M. J., Vidal, J., Gravalos, C., Polo, E., Jimenez-Fonseca, P., Gil Calle, … Read More
Correlative analysis of ctDNA in CheckMate-9X8 study of frontline treatment with mFOLFOX6, bevacizumab with or without nivolumab in metastatic colorectal cancer
Yao, J., Huang, Y., Tam, R., Cruz, A., Selby, R., Parikh, A. R., Yoshino, T., Tabernero, J., Jia, S., Novosiadly, … Read More
Additional health-related quality of life (Hrqol) analysis from DESTINY-Gastric04 (DG-04), a randomized phase 3 study of trastuzumab deruxtecan (T-dxd) vs ramucirumab (Ram) + paclitaxel (Ptx) in patients (Pts) with human epidermal growth factor receptor 2–positive (Her2+) unresectable/metastatic gastric cancer (Gc)/gastroesophageal junction adenocarcinoma (Geja)
Shitara, K., Zaanan, A., Lonardi, S., De La Fouchardière, C., Coutzac, C., Van Cutsem, E., Dekervel, J., Shen, L., Franke, … Read More
KEYNOTE-811: 6-year median follow-up of pembrolizumab plus trastuzumab and chemotherapy for previously untreated advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma
Kawazoe, A., Rha, S. Y., Bai, Y., Xu, J., Lonardi, S., Metges, J. P., Yanez Weber, P. E., Wyrwicz, L., … Read More
Efficacy of durvalumab and safety by treatment period in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (Flot) chemotherapy in resectable gastric/gastroesophageal junction (G/gej) cancer
Wainberg, Z. A., Van Cutsem, E., Götze, T., Sendur, M. A. N., Al-Farhat, Y., Wysocki, P. J., Mansoor, W., Bitzer, … Read More
Characterization and management of gastrointestinal (Gi) adverse events (Aes) with zanidatamab + chemotherapy (Ct) ± tislelizumab in first-line (1l) HER2-positive (Her2+) locally advanced or metastatic gastroesophageal adenocarcinoma (Mgea): Analysis from HERIZON-GEA-01
Elimova, E., Rha, S. Y., Shitara, K., Liu, T., Tabernero, J., Lee, K.-W., Schenker, M., Tebbutt, N. C., Ajani, J. … Read More
Zanidatamab with and without tislelizumab in her2-positive gastroesophageal cancer
Shitara, K., Elimova, E., Liu, T., Tabernero, J., Lee, K.-W., Schenker, M., Tebbutt, N. C., Ajani, J., Salimin, N., Ku, … Read More
From Mental Hygiene—and Its Entanglement with Eugenics—to the Human Right to Health: Brock Chisholm and the Production of the “World Citizen”
Pérez-Pérez, Beatriz. (2026). From Mental Hygiene—and Its Entanglement with Eugenics—to the Human Right to Health: Brock Chisholm and the Production … Read More
The changes in perceived self-efficacy, academic engagement, and empathy following simulation-based learning among undergraduate physiotherapy students: A quasi-experimental study
Ochandorena-Acha, M., Jolis-Prat, R., Escribà-Salvans, A., Oliveira, V. R., Rierola-Fochs, S., Parés-Martínez, C., & Terradas-Monllor, M. (2026). The changes in … Read More
Presentació: La presència callada
Godayol, P., Julio, T. (2026). Presentació: La presència callada. Quaderns. Revista de Traducció, 33, 7-9. https://doi.org/10.5565/rev/quaderns.260 (Editorial)
Isabel Oyarzábal: Compromiso político, traducción y escritura
Julio, T. (2026). Isabel Oyarzábal: Compromiso político, traducción y escritura. Quaderns. Revista de Traducció, 33, 59-69. https://doi.org/10.5565/rev/quaderns.185
Feminisme marxista censurat als anys setanta
Godayol, P. (2026). Feminisme marxista censurat als anys setanta. Quaderns. Revista de Traducció, 33, 71-86. https://doi.org/10.5565/rev/quaderns.183
The paradox of physical activity in relation to well-being and mental health: A compositional data analysis of the 24-hour movement patterns
Codina-Nadal, A., Dowd, K., Cirera-Viñolas, E., McKenna, J., Jabardo-Camprubí, G., Molist, G., Corominas, A., Torrejón, A., & Puig-Ribera, A. (2026). … Read More
Forensic linguistic evidence of psychological abuse and discursive manipulation in cyberstalking cases
Benedetti, N., & Queralt, S. (2026). Forensic linguistic evidence of psychological abuse and discursive manipulation in cyberstalking cases. Journal of … Read More
Association between the introduction of pediatric influenza vaccination and influenza diagnoses in primary care and hospitalizations: An interrupted time series study
Burgaya-Subirana, S., Ruiz-Comellas, A., Miró-Catalina, Q., Dorca Vila, J., Rovira Girabal, N., Ruiz, M., & Balaguer, M. (2026). Association between … Read More